Literature DB >> 26051686

Losartan: Comprehensive Profile.

Abdul-Rahman A Al-Majed1, Ebrahim Assiri2, Nasr Y Khalil2, Hatem A Abdel-Aziz2.   

Abstract

Losartan (Cozaar™) is an angiotensin II receptor antagonist with antihypertensive activity. It is used in the management of hypertension and heart failure. Nomenclature, formulae, elemental analysis, and appearance of the drug are included in this review. The uses, applications, and the variety of synthetic pathways of this drug are outlined. Physical characteristics including: ionization constant, solubility, X-ray powder diffraction pattern, thermal methods of analysis, UV spectrum, IR spectrum, mass spectrum with fragmentation patterns, and NMR (1H and 13C) spectra of losartan together with the corresponding figures and/or tables are all produced. This profile also includes the monograph of British Pharmacopoeia, together with several reported analytical methods including: spectrophotometric, electrochemical, chromatographic, and capillary electrophoretic methods. The stability, the pharmacokinetic behavior and the pharmacology of the drug are also provided.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiotensin II receptor antagonist; Description; Losartan; Methods of analysis; Methods of preparation; Pharmacokinetics; Physical characteristics; Spectral properties; Stability

Mesh:

Substances:

Year:  2015        PMID: 26051686     DOI: 10.1016/bs.podrm.2015.02.003

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  10 in total

1.  A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans.

Authors:  Shu-Han Chang; Ching-Chia Chang; Li-Jing Wang; Wei-Ching Chen; Shu-Yu Fan; Chi-Zong Zang; Ya-Hui Hsu; Mei-Chih Lin; Su-Hsiang Tseng; Der-Yuan Wang
Journal:  J Food Drug Anal       Date:  2020-06-15       Impact factor: 6.157

2.  Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia.

Authors:  Antonio Vitiello; Raffaele La Porta; Ugo Trama; Valentina Troiano; Francesco Ferrara
Journal:  Inflammopharmacology       Date:  2022-03-15       Impact factor: 5.093

3.  Angiotensin AT1 receptor antagonism by losartan stimulates adipocyte browning via induction of apelin.

Authors:  Dong Young Kim; Mi Jin Choi; Tae Kyung Ko; Na Hyun Lee; Ok-Hee Kim; Hyae Gyeong Cheon
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

Review 4.  Management of Hypertension Using Olmesartan Alone or in Combination.

Authors:  Xiaoshen Zhang; Han Zhang; Yuxia Ma; Wenliang Che; Michael R Hamblin
Journal:  Cardiol Ther       Date:  2017-03-03

5.  Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.

Authors:  Chunmei Li; Rui Han; Le Kang; Jianping Wang; Yonglin Gao; Yanshen Li; Jie He; Jingwei Tian
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

6.  Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats.

Authors:  Gabriel Mulinari-Santos; Jaqueline Silva Dos Santos; Letícia Pitol Palin; Ana Cláudia Ervolino da Silva; Cristina Antoniali; Leonardo Perez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

7.  Comparison of the GPVI inhibitors losartan and honokiol.

Authors:  Marie-Blanche Onselaer; Magdolna Nagy; Chiara Pallini; Jeremy A Pike; Gina Perrella; Lourdes Garcia Quintanilla; Johannes A Eble; Natalie S Poulter; Johan W M Heemskerk; Steve P Watson
Journal:  Platelets       Date:  2019-03-08       Impact factor: 3.862

Review 8.  Prescribed drugs containing nitrogen heterocycles: an overview.

Authors:  Majid M Heravi; Vahideh Zadsirjan
Journal:  RSC Adv       Date:  2020-12-15       Impact factor: 4.036

Review 9.  Influence of CYP2C9 Genetic Polymorphisms on the Pharmacokinetics of Losartan and Its Active Metabolite E-3174: A Systematic Review and Meta-Analysis.

Authors:  Yoon-A Park; Yu-Bin Song; Jeong Yee; Ha-Young Yoon; Hye-Sun Gwak
Journal:  J Pers Med       Date:  2021-06-29

10.  Modulation of Epithelial Mesenchymal Transition after AGTR-1 Gene Edition by Crispr/Cas9 and Losartan Treatment in Mammary Tumor Cell Line: A Comparative Study between Human and Canine Species.

Authors:  Marina Gobbe Moschetta-Pinheiro; Jucimara Colombo; Bianca Lara Venâncio de Godoy; Julia Ferreira Balan; Bianca Carlos Nascimento; Debora Aparecida Pires de Campos Zuccari
Journal:  Life (Basel)       Date:  2021-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.